| Year |
Citation |
Score |
| 2021 |
Nikhar S, Siokas I, Schlicher L, Lee S, Gyrd-Hansen M, Degterev A, Cuny GD. Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling. European Journal of Medicinal Chemistry. 215: 113252. PMID 33601309 DOI: 10.1016/j.ejmech.2021.113252 |
0.579 |
|
| 2019 |
Macdonald JD, Chacon Simon S, Han C, Wang F, Shaw JG, Howes JE, Sai J, Yuh J, Camper DV, Alicie BM, Alvarado J, Nikhar S, Payne WG, Aho ER, Bauer J, et al. Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Protein-Protein Interaction. Journal of Medicinal Chemistry. PMID 31724864 DOI: 10.1021/Acs.Jmedchem.9B01411 |
0.322 |
|
| 2018 |
Hrdinka M, Schlicher L, Dai B, Pinkas DM, Bufton JC, Picaud S, Ward JA, Rogers C, Suebsuwong C, Nikhar S, Cuny GD, Huber KV, Filippakopoulos P, Bullock AN, Degterev A, et al. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling. The Embo Journal. PMID 30026309 DOI: 10.15252/Embj.201899372 |
0.534 |
|
| 2017 |
Akasaka H, Thaliachery N, Zheng X, Blumenthal M, Nikhar S, Murdoch EE, Ling Q, Ruan KH. The key residue within the second extracellular loop of human EP3 involved in selectively turning down PGE2-and retaining PGE1-mediated signaling in live cells. Archives of Biochemistry and Biophysics. PMID 28065721 DOI: 10.1016/J.Abb.2016.12.001 |
0.385 |
|
| 2016 |
Vippila MR, Nikhar S, Gracia AP, Cuny GD. Divergent Approach for the Synthesis of Gombamide A and Derivatives. Organic Letters. PMID 27603447 DOI: 10.1021/Acs.Orglett.6B02379 |
0.338 |
|
| 2013 |
Banerji B, Pramanik SK, Sanphui P, Nikhar S, Biswas SC. Synthesis and cytotoxicity studies of novel triazolo-benzoxazepine as new anticancer agents. Chemical Biology & Drug Design. 82: 401-9. PMID 23672315 DOI: 10.1111/Cbdd.12164 |
0.399 |
|
| Show low-probability matches. |